PEAK6 Investments’s Guardant Health GH Stock Holding History

PEAK6 Investments’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$54K	–	4705
2022 Q3	$54K	Sell	1,000 -9,000	-90%	-$462K	﹤0.01%	4329
2022 Q2	$403K	Buy	10,000 +9,700	+3,233%	+$481K	﹤0.01%	4056
2022 Q1	$20K	Sell	300 -35,900	-99%	-$2.46M	﹤0.01%	4731
2021 Q4	$3.62M	Sell	36,200 -109,900	-75%	-$11.4M	0.01%	1385
2021 Q3	$18.3M	Buy	146,100 +14,300	+11%	+$1.7M	0.04%	426
2021 Q2	$16.4M	Buy	131,800 +900	+0.7%	+$121K	0.04%	451
2021 Q1	$20M	Buy	130,900 +128,900	+6,445%	+$19.5M	0.05%	355
2020 Q4	$258K	Sell	2,000 -6,300	-76%	-$725K	﹤0.01%	3597
2020 Q3	$928K	Hold	8,300	–	–	﹤0.01%	2339
2020 Q2	$673K	Buy	8,300 +1,500	+22%	+$121K	﹤0.01%	2430
2020 Q1	$473K	Sell	6,800 -37,500	-85%	-$2.88M	﹤0.01%	2123
2019 Q4	$3.46M	Sell	44,300 -36,200	-45%	-$2.61M	0.02%	789
2019 Q3	$5.14M	Buy	80,500 +47,800	+146%	+$4.21M	0.03%	653
2019 Q2	$2.82M	Buy	+32,700	New	+$2.5M	0.02%	1044

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PEAK6 Investments's GH Position: Q3 2023 in Review

PEAK6 Investments sold out of Guardant Health (GH) in Q3 2023, closing a stake of 5,998 shares — an estimated $215K sold.

PEAK6 Investments first reported a position in GH in Q2 2019 and held it in 11 quarters. The position peaked at $2.63M in Q3 2019. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

PEAK6 Investments reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
PEAK6 Investments sold 5,998 Guardant Health shares in Q3 2023, an estimated $215K.
PEAK6 Investments first reported a position in Guardant Health in Q2 2019 and held it in 11 quarters.
PEAK6 Investments's Guardant Health position peaked at $2.63M in Q3 2019.
296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.